C286, an orally available retinoic acid receptor β agonist drug, regulates multiple pathways to achieve spinal cord injury repairMaria B. Goncalves(King's College London), Jonathan Corcoran(King's College London)Frontiers in Molecular NeuroscienceAugust 20, 202410.3389/fnmol.2024.1411384Cited by 1SaveCiteExport RISWatch citationsRelated PapersNeuronal RARβ Signaling Modulates PTEN Activity Directly in Neurons and via Exosome Transfer in Astrocytes to Prevent Glial Scar Formation and Induce Spinal Cord Regeneration|Journal of Neuroscience|2015|97